COMMON STOCK PURCHASE WARRANT ENVERIC BIOSCIENCES, INC.Common Stock Purchase Warrant • February 15th, 2022 • Enveric Biosciences, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [•] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 15, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Enveric BioSciences, Inc., a Delaware corporation (the “Company”), up to [•] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
UNDERWRITING AGREEMENT between ENVERIC BIOSCIENCES, INC. and as Representative of the Several Underwriters ENVERIC BIOSCIENCES, INC.Underwriting Agreement • February 15th, 2022 • Enveric Biosciences, Inc. • Pharmaceutical preparations • New York
The undersigned, Enveric BioSciences, Inc., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
